Rolziracetam
From Wikipedia, the free encyclopedia
 |
|
 |
|
| Clinical data | |
|---|---|
| Routes of administration |
Oral |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| Synonyms | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
| CAS Number | 18356-28-0  |
| PubChem (CID) | 71893 |
| ChemSpider | 64906  |
| UNII | RES9I0LGG5 |
| ChEMBL | CHEMBL51396 |
| Chemical and physical data | |
| Formula | C7H9N2O2 |
| Molar mass | 139.152 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
See also[edit]
References[edit]
- ^ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
